Navigation Links
FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
Date:3/31/2011

SAN DIEGO, March 31, 2011 /PRNewswire/ -- Polaris Group (Polaris) today announced that the U.S. Food & Drug Administration (FDA) has approved the company's Special Protocol Assessment (SPA) for a Phase 3 clinical trial of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced hepatocellular carcinoma (HCC). The randomized, placebo-controlled, global trial will enroll approximately 600 patients who have failed prior systemic chemotherapy. The primary endpoint of the study is overall survival.

Ghassan Abou-Alfa, M.D., of Memorial Sloan-Kettering Cancer Center in New York, is the principal investigator of the study.  

"ADI-PEG 20 has demonstrated medical benefit in prior studies in multiple indications with a remarkable safety profile," said Dr. Abou-Alfa. "I am delighted to lead this study to explore ADI-PEG 20 as a viable option for patients with advanced liver malignancies."

SPA is a mechanism that allows the FDA and drug developers to reach an agreement prior to study initiation about the design and size of a Phase 3 trial. It will form the primary basis of an efficacy claim in a marketing application.

"The SPA agreement with the FDA is a key step in our plans for the clinical development of ADI-PEG 20," said John Bomalaski, M.D., executive vice president, medical affairs, of Polaris. "We are pleased to move ADI-PEG 20 into a pivotal Phase 3 trial and to be working with such well-established hepatocellular carcinoma experts."

Leo Chen, M.D., the lead investigator of the Phase 2 HCC study in Taiwan, stated, "Our Phase 2 study demonstrated that ADI-PEG 20 was effective and well-tolerated in patients with advanced liver cancer, and we look forward to the opportunity to further assess the efficacy and safety of this drug in a large randomized Phase 3 study."

The lead investigator in China, Shukui Qin, M.D., president of the Chinese Society of Clinical Oncology and chair of the Chinese Liver Cancer Stu
'/>"/>

SOURCE Polaris Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
2. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
3. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
4. FDA Approves Gadavist for Central Nervous System Scans
5. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
6. FDA Approves Device to Maintain Blood Flow During Artery Bypass Brain Surgery
7. FDA Approves BENLYSTA® for Lupus in Breakthrough for Millions of Sufferers
8. FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD
9. UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
10. FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
11. FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and LYON, France , Dec. ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ... developing an ultra-rapid insulin, known as BioChaperone Lispro, for ... diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology ... Lilly and Adocia will develop BioChaperone Lispro with the ...
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... 17, 2014  Beamz Interactive, Inc. (OTCQB: BZIC), ... today announced that it has signed an agreement ... supplier of innovative prosthetic, orthotic and assistive technology ... the agreement, RSL Steeper will promote and supply ... for use within UK residential care facilities through ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... N.J., March 3, 2011 ConvaTec Healthcare, a world-leading ... community and hospital care, today announced that, recognizing favorable ... option to refinance all or a portion of its ... 22, 2010. While the year-end audit ...
... A new report released by the UNT Health ... East Texas are breathing a little easier due in part ... center,s Center for Professional and Continuing Education regarding ... (COPD).  The report shows that the educational program contributed ...
Cached Medicine Technology:ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 2Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 4
(Date:12/21/2014)... Theme and plugin developers ... plugin for Final Cut Pro X entitled ProMotion. , ... more with absolute ease.” Said Christiana Austin, CEO of ... needed to easily animate their media inside FCPX.” , ... users to animate pictures, videos, logos, and more with ...
(Date:12/20/2014)... BambooIndustry.com is a professional company offering ... has recently shown its new engineered bamboo flooring collection, ... flooring models. , BambooIndustry.com’s customers come from many countries ... According to the CEO of the company, the global ... the past few years, and the demand for eco-friendly ...
(Date:12/20/2014)... 20, 2014 Dress company LunaDress has recently ... announced its Christmas Sale, offering big discounts on all of ... has an idea to own a perfect wedding gown. If ... wedding dress, then come to LunaDress. Many different wedding dress ... Visit our website now and enjoy the current special offer, ...
(Date:12/20/2014)... Doctor’s Office Urgent Care of Paramus, New Jersey has served ... They’ve treated over 40,000 patients while carrying out their mission ... the Paramus area. , For 2015, the practice is ... top-notch board certified physicians: Christine Milosis MD, Sandra Ugras Rey ... will work tirelessly to carry out The Doctor’s Office ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer ... coming Christmas. In the promotion, all buyers worldwide can ... have something special for the women who are looking ... our new collections of 2015 dresses have been unveiled ... greatly discounted prices. Visit our website now before they ...
Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
... new ways of controlling and treating breast cancer at ... (Monday 1 October 2007). , Dr Robert Clarke and ... have been investigating human breast cancers for the presence ... and can cause the cancer to recur - in ...
... 1 In honor of October, Breast Cancer,Awareness Month, ... the Cure,encourages San Diegans to participate in a number ... Komen for the Cure can help the,organization in its ... awareness in San Diego County. "We encourage all ...
... on Spotting Depression in Children, BETHLEHEM, Pa., Oct. ... by depression each year, but even as thousands of,sites ... and educate them,about the condition on National Depression Screening ... a largely overlooked part of our,population: children. In ...
... Jobs With ... Congressman Rodney Frelinghuysen, PARSIPPANY, N.J., Oct. 1 ... and rapidly increasing its,staffing since 2002 to support a growing ... Sankyo is,one of the few pharmaceutical companies experiencing steady and ...
... raise funds,through in-store ,pin-up, campaign, ALEXANDRIA, Va., Oct. ... Kmart has reinforced its,commitment to ADA and elevated its ... Partner (NSP). As a National Strategic,Partner, Kmart will raise ... and cure diabetes, and to improve the lives of ...
... bug busting approach to head lice is helping to reduce ... to a review in the October issue of Journal of ... Hygiene Concern led a review of studies carried out in ... The best results are obtained when parents are supplied with ...
Cached Medicine News:Health News:Manchester researchers announce new methods of beating breast cancer 2Health News:In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer 2Health News:In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 2Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 4Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 4Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 6Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 7Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 8Health News:Kmart Steps Out to Fight Diabetes 2Health News:Kmart Steps Out to Fight Diabetes 3Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 2Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 3
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: